1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. CIDARA THERAPEUTICS INC
Cidara Therapeutics Inc XNAS: CDTX

Cidara Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprise...

Read More
105.99 -1.13 (-1.05%)
698.72% Gain from 52W Low
545.4K
XNAS Volume

XNAS 13 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Cidara Therapeutics Inc is on 17 Nov 2025 for the purpose of Cidara Therapeutics Jefferies London Healthcare Conference 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
4.7 / 100
Momentum Score
Technically Moderately Bullish
68.9 / 100
Analyst Price Target
161
1Yr Price target upside is 52%
7 analysts

12

S

7

W

6

O

0

T

SWOT Analysis

Cidara Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..